Ex Parte Kustov et al - Page 7



          Appeal No. 2006-0753                                                        
          Application No. 09/682,010                                                  

          unexpected results relative to the closest prior art range,                 
          thereby rebutting any prima facie case established by the                   
          examiner.  See the Reply Brief, page 2.  In support of this                 
          argument, the appellants for the first time refer to Example 1,             
          as shown by Table 1, at pages 8 and 9 of the specification.  Id.            
          This argument, however, is considered waived since the appellants           
          fail to raise it in the opening Brief.  Cross Med. Prods., Inc.             
          v. Medtronic Sofamor Danek, Inc., 424 F.3d 1293, 1320-21 n.3,               
          76 USPQ2d 1662, 1683 n.3 (Fed. Cir. 2005)(Arguments not raised              
          in the opening brief are considered waived.).                               
               To the extent that it is not waived, the appellants have not           
          demonstrated that the showing referred to is commensurate in                
          scope with the degree of protection sought by the claims on                 
          appeal.  In re Grasselli, 713 F.2d 731, 743, 218 USPQ 769, 778              
          (Fed. Cir. 1983); In re Clemens, 622 F.2d 1029, 1035, 206 USPQ              
          289, 296 (CCPA 1980).  While the showing is limited to calcining            
          powder form of HZSM-5 having a Si/Al ratio equal to 21 dispersed            
          in 400 mg of quartz grains of the same size at an initial                   
          temperature of 350oC for 5 hours under nitrogen or air flow (60             
          ml/min) and at a second higher temperature for an unknown period            
          under nitrogen or air flow and then cooling the calcined HZSM-5             

                                          7                                           




Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007